Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,209.85
-0.3%
-20.27
Arrow-Thin-Down
DJI
49,068.22
-0.9%
-431.05
Arrow-Thin-Down
NASDAQ
25,097.75
-0.1%
-16.69
Arrow-Thin-Down
Bitcoin
$80,489.00
+2.3%
+$1,774.46
Arrow-Thin-Down
AAPL
$277.17
-1.1%
-$2.97
Arrow-Thin-Down
AMZN
$271.30
+1.1%
+$3.04
Arrow-Thin-Down
GOOG
$381.21
-0.5%
-$2.01
Arrow-Thin-Down
META
$612.47
+0.6%
+$3.73
Arrow-Thin-Down
MSFT
$414.94
+0.1%
+$0.50
Arrow-Thin-Down
NVDA
$199.09
+0.3%
+$0.64
Arrow-Thin-Down
TSLA
$391.92
+0.3%
+$1.10
Most Active StocksDaily Stock GainersDaily Stock Losers

Hemab Therapeutics

(NASDAQ) COAG

Current Price$29.20
Market Cap$60.59M
Since IPO (2026)+89%
5 YearN/A
1 YearN/A
1 MonthN/A

Hemab Therapeutics Financials at a Glance

Market Cap

$60.59M

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$29.20

Volume

453,228.646

Open

$30.87

Previous Close

$34.00

Daily Range

$27.76 - $32.00

52-Week Range

$18.00 - $36.61

COAG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hemab Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

72

CEO

Benny Sorensen, MD, PhD

Website

www.hemab.com

Headquarters

Cambridge, MA 02142, US

COAG Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$60.59M

Shares Outstanding

1.78M

Volume

453.23K

Avg. Volume

2.06M

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Hemab Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$60.59M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7230.12+0.00%
^DJIDJI
$49499.27-0.00%
^IXICNASDAQ
$25114.44+0.01%
BTCBitcoin
$78633.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$8.42+2.64%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.16+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.00%
SOUNSoundHound AI
$9.70+0.01%

Questions About COAG

What is the current price of Hemab Therapeutics?

Hemab Therapeutics is trading at $29.22 per share.

What is the 52-week range for Hemab Therapeutics?

Over the past 52 weeks, Hemab Therapeutics has traded between $18.00 and $36.61.

How much debt does Hemab Therapeutics have?

As of the most recent reporting period, Hemab Therapeutics reported total debt of $361.43M.

How much cash does Hemab Therapeutics have on hand?

Hemab Therapeutics reported $87.97M in cash and cash equivalents in its most recent financial results.

What is Hemab Therapeutics’s dividend yield?

Hemab Therapeutics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services